Berberine: a potential phytochemical with multispectrum therapeutic activities

Bibliography

• General guidelines for methodologies on research and evaluation of traditional medicine. World Health Organization, Geneva, WHO/EDM/TRM/2000.1,2000;1–73. Available from: http://www.paho.org/spanish/ad/ths/ev/PM-WHOTraditional-medicines-research-evaluation.pdf [Last accessed 14 June 2010]
   Google Scholar
• Patwardhan B, Hopper ML. Ayurveda and future drug development. J Altern Complement Med 1992;3:9-11
   Google Scholar
• Arayne MS, Sultana N, Bahadur SS, The berberis story: Berberis vulgaris in therapeutics. Pak J Pharm Sci 2007;20:83-92
   PubMed Web of Science ®Google Scholar
• Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008;22:999-1012
   PubMed Web of Science ®Google Scholar
• Chevalier A. Encyclopedia of medicinal plants, Revised Edition. Sydney (AUS): Dorling Kindersley; 2001
   Google Scholar
• Cernakova M, Kostalova D. Antimicrobial activity of berberine – a constituent of Mahonia aquifolium. Folia Microbiol (Praha) 2002;47:375-8
   PubMed Web of Science ®Google Scholar
• Bensky D, Gamble A, Kapchuk T. Chinese herbal medicine: materia medica. 3rd edition. Seattle: Eastland; 1993
   Google Scholar
• Sack RB, Froehlich JL. Berberine- one herb in many ways. Altern Med Rev 2000;5:175-7
   PubMedGoogle Scholar
• Kaneda Y, Torii M, Tanaka T, In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Ann Trop Med Parasitol 1991;85:417-25
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Bhattacharyya FK, Ghosh DK. Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp Parasitol 1985;60:404-13
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Tanaka T, Saw T. Effects of berberine, a plant alkaloid, on the growth of anaerobic protozoa in axenic culture. Tokai J Exp Clin Med 1990;15:417-23
   PubMedGoogle Scholar
• Nair KP. Giardiasis in children. Pediatr Clin India 1970;5:45
   Google Scholar
• Choudhry VP, Sabir M, Bhide VN. Berberine in giardiasis. Indian Pediatr 1972;9:143-6
   PubMedGoogle Scholar
• Sheng WD, Jiddawi MS, Hong XQ, Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Afr Med J 1997;74:283-4
   PubMed Web of Science ®Google Scholar
• Swabb EA, Tai YH, Jordan L. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol 1981;241:G248-52
   PubMed Web of Science ®Google Scholar
• Sack RB, Froehlich JL. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 1982;35:471-5
   PubMed Web of Science ®Google Scholar
• Yuan J, Shen XZ, Zhu XS. Effect of berberine on transit time of human small intestine. Zhongguo Zhong Xi Yi Jie He Za Zhi 1994;14:718-20
   PubMedGoogle Scholar
• Sun D, Abraham SN, Beachey EH. Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli. Antimicrob Agents Chemother 1988;32:1274-77
   PubMed Web of Science ®Google Scholar
• Hostettmann K, Marston A, Maillard M, Phytochemistry of plants used in traditional medicine. Clarendon press, Oxford; 1995
   Google Scholar
• Szeto S, Yow CMN, Fung KW. Characterization of berberine on human cancer cells in culture. Turk J Med Sci 2002;32:363-8
   Google Scholar
• Lin TH, Kuo HC, Chou FP, Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008;8:58
   PubMed Web of Science ®Google Scholar
• Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006;5:296-308
   PubMed Web of Science ®Google Scholar
• Sun Y, Xun K, Wang Y, A systematic review of the anti cancer properties of berberine, a natural product from Chinese herbs. AntiCancer Drugs 2009;20:757-69
   PubMed Web of Science ®Google Scholar
• Kong WJ, Zhang H, Song DQ, Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 2009;58:109-19
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou S, Tang J, Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 2009;606:262-8
   PubMed Web of Science ®Google Scholar
• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008;57:712-17
   PubMed Web of Science ®Google Scholar
• Kulkarni SK, Dhir A. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol 2007;569:77-83
   PubMed Web of Science ®Google Scholar
• Kulkarni SK, Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 2008;589:163-72
   PubMed Web of Science ®Google Scholar
• Peng WH, Lo KL, Lee YH, Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci 2007;81:933-8
   PubMed Web of Science ®Google Scholar
• Abidi P, Zhou Y, Jiang JD, Liu J. Extra cellular signal regulated kinase- dependent stabilization of hepatic low density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol 2005;25:2170-6
   PubMed Web of Science ®Google Scholar
• Lee S, Lim HJ, Park JH, Berberine-induced LDLR up-regulation involves JNK pathway. Biochem Biophys Res Commun 2007;362:853-7
   PubMed Web of Science ®Google Scholar
• Brusq JM, Ancellin N, Grondin P, Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 2006;47:1281-8
   PubMed Web of Science ®Google Scholar
• Kong W, Wei J, Abidi P, Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10:1344-51
   PubMed Web of Science ®Google Scholar
• Cicero AF, Rovati LC, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. Arzneimittelforschung 2007;57:26-30
   PubMed Web of Science ®Google Scholar
• Fatehi-Hassanabad Z, Zafarzadeh M, Tarhini A, The anti hypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rat. Physiother Res 2005;19:222-5
   Web of Science ®Google Scholar
• Chun YT, Yip TT, Lau KL, A biochemical study on the hypotensive effect of berberine in rats. Gen Pharmacol 1979;10:177-82
   PubMedGoogle Scholar
• Wong KK. Mechanism of the aortic relaxation induced by low concentrations of berberine. Planta Med 1998;64:756-7
   PubMed Web of Science ®Google Scholar
• Kang DG, Sohn EJ, Kwon EK, Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascul Pharmacol 2002;39:281-6
   PubMed Web of Science ®Google Scholar
• Olmez E, Ilhan M. Evaluation of alpha-adrenoreceptor antagonistic action of berberine in isolated organs. Arzneimittelforschung 1992;42:1095-97
   PubMed Web of Science ®Google Scholar
• Chiou WF, Yen MH, Chen CF. Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur J Pharmacol 1991;204:35-40
   PubMed Web of Science ®Google Scholar
• Cheng bin, Yao Wei-xing, Fang Da-chao, Cardiovascular aspects of pharmacology of berberine: I. Alpha-adrenoreceptor blocking action of berberine in isolated rat anococcygeus muscle and rabbit aortic strip. J Tongji Med Univ 1987;7:239-41
   PubMedGoogle Scholar
• Lau CW, Yao XQ, Chen ZY, Cardiovascular actions of berberine. Cardiovasc Drug Rev 2001;19:234-44
   PubMed Web of Science ®Google Scholar
• Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004;203:127-37
   PubMed Web of Science ®Google Scholar
• The Ayurvedic pharmacopoeia of India, Part-I, Volume – II. Government of India, Ministry of health and family welfare, Department of Ayush. Available from: http://ccras.nic.in/PharmacopoeialWork/Links/API/API-Vol-2.pdf [Last accessed 14 June 2010]
   Google Scholar
• A Berberine a Day may Keep the Doctor at Bay (Modern Transportation and the Human Heart). Available from: http://www.truebotanica.com/berberine_transportation_heart.html [Last accessed 14 June 2010]
   Google Scholar
• Kim RB. Transporters and drug discovery: why, when, and how. Mol Pharm 2006;3:26-32
   PubMed Web of Science ®Google Scholar
• Kunta JR, Sinko PJ. Intestinal drug transporters: in vivo function and clinical importance. Curr Drug Metab 2004;5:109-24
   PubMed Web of Science ®Google Scholar
• Ayrton A, Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 2001;31:469-97
   PubMed Web of Science ®Google Scholar
• Zhang L, Strong JM, Qiu W, Scientific perspectives on drug transporters and their role in drug interactions. Mol Pharm 2006;3:62-9
   PubMed Web of Science ®Google Scholar
• Fardel O, Lecureur V, Guillouzo A. The P-glycoprotein multidrug transporter. Gen Pharmacol 1996;27:1283-91
   PubMedGoogle Scholar
• Ambudkar SV, Kim IW, Sauna ZE. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). Eur J Pharm Sci 2006;27:392-400
   PubMed Web of Science ®Google Scholar
• Loo TW, Clarke DM. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J Membr Biol 2005;206:173-85
   PubMed Web of Science ®Google Scholar
• Varma MV, Perumal OP, Panchagnula R. Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Curr Opin Chem Biol 2006;10:367-73
   PubMed Web of Science ®Google Scholar
• Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004;25:423-9
   PubMed Web of Science ®Google Scholar
• Thiebaut F, Suruo TT, Hamada H, Cellular localization of the multi drug resistence gene product p-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735-8
   PubMed Web of Science ®Google Scholar
• Mouly S, Paine MF. P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 2003;20:1595-9
   PubMed Web of Science ®Google Scholar
• Varma MV, Sateesh K, Panchagnula R. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Mol Pharm 2005;2:12-21
   PubMed Web of Science ®Google Scholar
• Varma MV, Ashokraj Y, Dey CS, P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 2003;48:347-59
   PubMed Web of Science ®Google Scholar
• Chiou WL, Chung SM, Wu TC, A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans. Int J Clin Pharmacol Ther 2001;39:93-101
   PubMed Web of Science ®Google Scholar
• Breedveld P, Beijnen JH, Schellens JH. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci 2006;27:17-24
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. J Pharm Sci 2005;94:1694-704
   PubMed Web of Science ®Google Scholar
• Pan GY, Wang GJ, Liu XD, The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 2002;91:193-7
   PubMedGoogle Scholar
• Bansal T, Jaggi M, Khar RK, Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J Pharm Pharm Sci 2009;12:46-78
   PubMed Web of Science ®Google Scholar
• Bansal T, Akhtar N, Jaggi M, Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. Drug Discov Today 2009;14:1067-74
   PubMed Web of Science ®Google Scholar
• Lo YL. Relationship between the hydrophilic- lipophilic balance values of pharmaceutical excipients s and multi drug resistance modulating effect in Caco-2 cells and rat intestine. J Control Release 2003;90:37-48
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. Pluronic block co polymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008;130:98-106
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P, Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 2004;278:119-31
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch, Grabovac V. Polymeric efflux pump inhibitors in oral drug delivery. Am J Drug Deliv 2006;4:263-72
   Google Scholar
• Shen Q, Lin Y, Handa T, Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. Int J Pharm 2006;313:49-56
   PubMed Web of Science ®Google Scholar
• Sachs-Barrable K, Thamboo A, Lee SD, Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J Pharm Pharm Sci 2007;10:319-31
   PubMed Web of Science ®Google Scholar
• Tsai P, Tsai TH. Simultaneous determination of berberine in rat blood, liver and bile using microdialysis coupled to high-performance liquid chromatography. J Chromatogr A 2002;961:125-30
   PubMed Web of Science ®Google Scholar
• Delie F, Blanco-Prieto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 2005;10:65-80
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Mishra B, Singh S. Lipid – an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm 2009;73:1-15
   PubMed Web of Science ®Google Scholar
• Lai J, Lu Y, Yin Z, Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Int J Nanomedicine 2010;5:13-23
   PubMed Web of Science ®Google Scholar
• Xin HW, Wu XC, Li Q, Effects of coadministration of berberine chloride with cyclosporine on liver microsomal cytochrome P450 isoenzyme and mdr1 in rats. Chin Pharmacol Bull 2002;18:397-401
   Google Scholar
• Gui SY, Wu L, Peng DY, Preparation and evaluation of a microemulsion for oral delivery of berberine. Pharmazie 2008;63:516-19
   PubMed Web of Science ®Google Scholar
• Nassar T, Rom A, Nyska A, Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug. J Control Release 2009;133:77-84
   PubMed Web of Science ®Google Scholar